Oral Diseases · 2020 · 19 citations · 24 references
DentistryOncologyOral Cancer SurgeryOral OncologyTumor ImmunologyCancer Survival AnalysisOral Cancer PrognosisPreoperative Oncology AssessmentPrognosis AssessmentClinical Utility AnalysisClinical Utility AssessmentIndividualized Risk PredictionInverse Probability WeightingModel Calibration CurvesPredictive Model PerformancePredictive Performance EvaluationSurvival Curve Prediction
OBJECTIVE: To assess the association of preoperative lymphocyte-to-monocyte ratio (LMR) and overall survival (OS) in patients with oral cancer and develop a dynamic nomogram for individualized survival prediction. METHOD: The prognostic value of LMR was evaluated in a large-scale cohort with 651 postoperative patients with oral cancer between January 2010 and December 2017. Propensity score-matched (PSM) analysis and inverse probability of treatment weighting (IPTW) analysis were performed to further verify the prognostic value of LMR. A dynamic nomogram was then developed based on the LMR and clinicopathological features, and its predictive performance and clinical utility were evaluated. RESULTS: A high LMR was significantly associated with better OS of patients with oral cancer (HR = 0.65; 95% CI = 0.44-0.98). The similar association was also observed in the PSM and IPTW analyses. Moreover, compared with TNM staging system, the dynamic nomogram based on the LMR exhibited more excellent predictive performance (0.72 versus 0.64, p < .001), with calibration curves (1,000 bootstrap resamples) suggesting good match between the actual and predicted probabilities. Decision curve analyses (DCAs) showed a more significant positive net benefit in the practical ranges of threshold probabilities using the dynamic nomogram. CONCLUSION: Preoperative LMR may serve as an easily accessible and non-invasive prognostic biomarker for predicting the prognosis of patients with oral cancer. A dynamic nomogram based on the LMR may show more convenience in survival prediction for patients with oral cancer. Further future studies are warranted to confirm our findings.
24
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
Robert L. Camp, Marisa Dolled‐Filhart, David L. Rimm · Clinical Cancer Research · 2004 · 3.9K citations
Medicine, Biostatistics, Oncology +17
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl, Tang Lee, Sohrab P. Shah et al. · New England Journal of Medicine · 2010 · 1.3K citations · Full text
Jason S. Haukoos, Roger Lewis · JAMA · 2015 · 833 citations · Full text